BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 12:56:12 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-06-16 01:28 |
|
Peer-Review Started |
|
2025-06-16 01:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-07-16 08:06 |
|
Revised |
|
2025-07-18 10:23 |
|
Second Decision |
|
2025-09-08 02:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-09-08 07:44 |
|
Articles in Press |
|
2025-09-08 07:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-03 08:14 |
|
Publish the Manuscript Online |
|
2025-11-14 00:56 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Evaluation of pancreatic adenocarcinoma with tumor budding and lymphocytic infiltration as prognostic marker
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sunil V Jagtap and Shubham S Jagtap |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sunil V Jagtap, MD, Professor, Department of Pathology, Krishna Vishwa Vidyapeeth, Krishna Institute of Medical Sciences, Malkapur, Karad 415110, Maharashtra, India. drsvjagtap@gmail.com |
| Key Words |
Pancreatic ductal adenocarcinoma; Tumor-infiltrating lymphocytes; Tumor Budding; Prognostic marker; Evaluation |
| Core Tip |
Pancreatic ductal adenocarcinoma is highly invasive pancreatic neoplasm, having globally 495773 new cases and 466003 new deaths reported in 2020. This article is to evaluate the prognostic importance of tumor budding (TB) and tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinom and its correlation as prognostic marker. A high TB was a poor prognostic feature and might be a target for tumor-specific treatments. While high T-cell infiltration, especially of CD8+ T cells is linked to better outcomes. Future, TB and tumor lymphocytic infiltration should be taken into consideration and included in pathology reports. This knowledge is crucial for clinicians to better assess patient prognosis. |
| Publish Date |
2025-11-14 00:56 |
| Citation |
<p>Jagtap SV, Jagtap SS. Evaluation of pancreatic adenocarcinoma with tumor budding and lymphocytic infiltration as prognostic marker. <i>World J Gastrointest Oncol</i> 2025; 17(11): 110798</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i11/110798.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i11.110798 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
